Occudo Quantitative Strategies LP Buys New Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Occudo Quantitative Strategies LP bought a new stake in Privia Health Group, Inc. (NASDAQ:PRVA) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 10,567 shares of the company’s stock, valued at approximately $207,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. First Horizon Advisors Inc. grew its stake in shares of Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after acquiring an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after purchasing an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. acquired a new position in Privia Health Group in the fourth quarter valued at $51,000. Quadrant Capital Group LLC raised its holdings in shares of Privia Health Group by 11.8% in the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock valued at $95,000 after buying an additional 511 shares during the last quarter. Finally, Nisa Investment Advisors LLC increased its stake in shares of Privia Health Group by 185.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company’s stock worth $98,000 after acquiring an additional 3,249 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on PRVA. JMP Securities reiterated a “market outperform” rating and set a $29.00 price target on shares of Privia Health Group in a research note on Monday, April 28th. Robert W. Baird upped their target price on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 15th. Needham & Company LLC restated a “buy” rating and set a $30.00 target price on shares of Privia Health Group in a research report on Thursday, April 10th. Barclays upped their target price on shares of Privia Health Group from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 10th. Finally, Piper Sandler upped their price target on shares of Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Privia Health Group currently has a consensus rating of “Buy” and an average target price of $27.38.

Insider Buying and Selling

In other news, CEO Parth Mehrotra sold 15,100 shares of the business’s stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $352,283.00. Following the completion of the sale, the chief executive officer now owns 454,281 shares of the company’s stock, valued at approximately $10,598,375.73. The trade was a 3.22% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO David Mountcastle sold 5,630 shares of the business’s stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the sale, the chief financial officer now directly owns 179,676 shares of the company’s stock, valued at $4,021,148.88. The trade was a 3.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 51,579 shares of company stock valued at $1,226,367 in the last quarter. Company insiders own 10.70% of the company’s stock.

Privia Health Group Price Performance

Privia Health Group stock opened at $25.02 on Friday. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $26.09. The company has a market capitalization of $3.05 billion, a price-to-earnings ratio of 250.23, a price-to-earnings-growth ratio of 3.47 and a beta of 0.87. The firm’s fifty day moving average price is $23.36 and its 200 day moving average price is $22.54.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.